Acuta Capital Partners, LLC
Annual return
—
SPY
—
Alpha
—
Invested
$283.5M
Holdings
25
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$PRAX
PRAXIS PRECISION MEDICINES I
Q4 2025: Exited (was 49.8k shares)
19.8%
02
$TERN
TERNS PHARMACEUTICALS INC
Q4 2025: Exited (was 502.8k shares)
18.9%
03
$WHWK
WHITEHAWK THERAPEUTICS INC
Q4 2025: Exited (was 3.41M shares)
8.5%
04
$TNGX
TANGO THERAPEUTICS INC
Held since at least Q1 2024
6.7%
05
$DRUG
BRIGHT MINDS BIOSCIENCES INC
Q4 2025: Exited (was 84.9k shares)
5.9%
06
$STRO
SUTRO BIOPHARMA INC
Held since at least Q1 2024
4.9%
07
$ERAS
ERASCA INC
Held since at least Q1 2024
4.2%
08
$SRZN
SURROZEN INC
Q4 2025: Exited (was 178.4k shares)
3.6%
09
$OCUL
OCULAR THERAPEUTIX INC
Q4 2025: Exited (was 1.17M shares)
3.6%
10
$CMPX
COMPASS THERAPEUTICS INC
Q4 2025: Exited (was 840.1k shares)
3.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 08:46 UTC.